Search

Ralph J. Gitomer

Examiner (ID: 10080, Phone: (571)272-0916 , Office: P/1657 )

Most Active Art Unit
1657
Art Unit(s)
1803, 2899, 1651, 1657, 1815, 1655, 1627, 1623, 1622, 1211
Total Applications
3335
Issued Applications
2109
Pending Applications
286
Abandoned Applications
943

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4688971 [patent_doc_number] => 20080033152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'Three-Phase Partitioning Method for Purifying a Protein' [patent_app_type] => utility [patent_app_number] => 11/832830 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4516 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20080033152.pdf [firstpage_image] =>[orig_patent_app_number] => 11832830 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/832830
Three-phase partitioning method for purifying a protein Aug 1, 2007 Issued
Array ( [id] => 5120577 [patent_doc_number] => 20070142292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'COMPOSITION OF LACTOFERRIN RELATED PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/677796 [patent_app_country] => US [patent_app_date] => 2007-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 43570 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142292.pdf [firstpage_image] =>[orig_patent_app_number] => 11677796 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/677796
Composition of lactoferrin related peptides and uses thereof Feb 21, 2007 Issued
Array ( [id] => 4938832 [patent_doc_number] => 20080076151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Compositions for controlling hair growth' [patent_app_type] => utility [patent_app_number] => 11/709074 [patent_app_country] => US [patent_app_date] => 2007-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 28853 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076151.pdf [firstpage_image] =>[orig_patent_app_number] => 11709074 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/709074
Compositions for controlling hair growth Feb 20, 2007 Issued
Array ( [id] => 5242237 [patent_doc_number] => 20070020732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Mast cell-specific signal transducer and cDNA thereof' [patent_app_type] => utility [patent_app_number] => 11/529217 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3437 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020732.pdf [firstpage_image] =>[orig_patent_app_number] => 11529217 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/529217
Mast cell-specific signal transducer and cDNA thereof Sep 28, 2006 Issued
Array ( [id] => 5241759 [patent_doc_number] => 20070020251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Paralytic peptide for use in neuromuscular therapy' [patent_app_type] => utility [patent_app_number] => 11/507128 [patent_app_country] => US [patent_app_date] => 2006-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11655 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020251.pdf [firstpage_image] =>[orig_patent_app_number] => 11507128 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/507128
Paralytic peptide for use in neuromuscular therapy Aug 20, 2006 Issued
Array ( [id] => 5834671 [patent_doc_number] => 20060246502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Rabconnectin-3-binding protein' [patent_app_type] => utility [patent_app_number] => 11/483356 [patent_app_country] => US [patent_app_date] => 2006-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16205 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246502.pdf [firstpage_image] =>[orig_patent_app_number] => 11483356 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/483356
Rabconnectin-3-binding protein Jul 6, 2006 Issued
Array ( [id] => 5732383 [patent_doc_number] => 20060257500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'TRPC6 involved in glomerulonephritis' [patent_app_type] => utility [patent_app_number] => 11/417113 [patent_app_country] => US [patent_app_date] => 2006-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 8341 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11417113 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/417113
TRPC6 involved in glomerulonephritis May 3, 2006 Abandoned
Array ( [id] => 5678538 [patent_doc_number] => 20060183894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors' [patent_app_type] => utility [patent_app_number] => 11/410777 [patent_app_country] => US [patent_app_date] => 2006-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 7142 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183894.pdf [firstpage_image] =>[orig_patent_app_number] => 11410777 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/410777
Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors Apr 24, 2006 Abandoned
Array ( [id] => 5596209 [patent_doc_number] => 20060160126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => '90 human secreted proteins' [patent_app_type] => utility [patent_app_number] => 11/375414 [patent_app_country] => US [patent_app_date] => 2006-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 197317 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160126.pdf [firstpage_image] =>[orig_patent_app_number] => 11375414 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/375414
90 human secreted proteins Mar 14, 2006 Abandoned
Array ( [id] => 5694971 [patent_doc_number] => 20060155118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Affinity purification system using troponin molecules as affinity ligands' [patent_app_type] => utility [patent_app_number] => 11/369285 [patent_app_country] => US [patent_app_date] => 2006-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18336 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20060155118.pdf [firstpage_image] =>[orig_patent_app_number] => 11369285 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/369285
Affinity purification system using troponin molecules as affinity ligands Mar 5, 2006 Abandoned
Array ( [id] => 466945 [patent_doc_number] => 07235385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Methods for enhancing expression of recombinant proteins' [patent_app_type] => utility [patent_app_number] => 11/358581 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9698 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235385.pdf [firstpage_image] =>[orig_patent_app_number] => 11358581 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/358581
Methods for enhancing expression of recombinant proteins Feb 20, 2006 Issued
11/341482 Complex for serving diabetics to reduce the concentration of blood glucose Jan 29, 2006 Abandoned
Array ( [id] => 418912 [patent_doc_number] => 07276584 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-10-02 [patent_title] => 'Isolated nucleic acid molecules encoding the Br2 P-glycoprotein of maize and methods of modifying growth in plants transformed therewith' [patent_app_type] => utility [patent_app_number] => 11/338199 [patent_app_country] => US [patent_app_date] => 2006-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19038 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/276/07276584.pdf [firstpage_image] =>[orig_patent_app_number] => 11338199 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/338199
Isolated nucleic acid molecules encoding the Br2 P-glycoprotein of maize and methods of modifying growth in plants transformed therewith Jan 23, 2006 Issued
Array ( [id] => 5596235 [patent_doc_number] => 20060160152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Purified Stat proteins and methods of purifying thereof' [patent_app_type] => utility [patent_app_number] => 11/335005 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 28982 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160152.pdf [firstpage_image] =>[orig_patent_app_number] => 11335005 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/335005
Purified Stat proteins and methods of purifying thereof Jan 18, 2006 Issued
Array ( [id] => 5733727 [patent_doc_number] => 20060258844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Algae fluorescence protein dry powder structure and manufacturing method thereof' [patent_app_type] => utility [patent_app_number] => 11/328193 [patent_app_country] => US [patent_app_date] => 2006-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1339 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258844.pdf [firstpage_image] =>[orig_patent_app_number] => 11328193 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/328193
Algae fluorescence protein dry powder structure and manufacturing method thereof Jan 9, 2006 Abandoned
Array ( [id] => 463014 [patent_doc_number] => 07238498 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Screening methods' [patent_app_type] => utility [patent_app_number] => 11/306504 [patent_app_country] => US [patent_app_date] => 2005-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6129 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238498.pdf [firstpage_image] =>[orig_patent_app_number] => 11306504 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/306504
Screening methods Dec 29, 2005 Issued
11/315810 Method for treating obesity with zinc-charged polypeptides Dec 21, 2005 Abandoned
Array ( [id] => 668517 [patent_doc_number] => 07094758 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'Apoptotic compounds' [patent_app_type] => utility [patent_app_number] => 11/294968 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14130 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094758.pdf [firstpage_image] =>[orig_patent_app_number] => 11294968 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/294968
Apoptotic compounds Dec 4, 2005 Issued
Array ( [id] => 5844930 [patent_doc_number] => 20060122376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Protein complexes having factor VIII:C activity and production thereof' [patent_app_type] => utility [patent_app_number] => 11/290051 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14884 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122376.pdf [firstpage_image] =>[orig_patent_app_number] => 11290051 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/290051
Protein complexes having factor VIII:C activity and production thereof Nov 29, 2005 Abandoned
Array ( [id] => 5716085 [patent_doc_number] => 20060079448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Compounds and methods for increasing neurogenesis' [patent_app_type] => utility [patent_app_number] => 11/288495 [patent_app_country] => US [patent_app_date] => 2005-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23943 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079448.pdf [firstpage_image] =>[orig_patent_app_number] => 11288495 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/288495
Compounds and methods for increasing neurogenesis Nov 27, 2005 Abandoned
Menu